CN114015749A - Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer - Google Patents

Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer Download PDF

Info

Publication number
CN114015749A
CN114015749A CN202111210004.9A CN202111210004A CN114015749A CN 114015749 A CN114015749 A CN 114015749A CN 202111210004 A CN202111210004 A CN 202111210004A CN 114015749 A CN114015749 A CN 114015749A
Authority
CN
China
Prior art keywords
amplification
primer
seq
primer pair
mitochondrial genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111210004.9A
Other languages
Chinese (zh)
Inventor
雷继海
华大颂
肖锐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Bosheng Medical Laboratory Co ltd
Zhejiang Bosheng Biological Technology Ltd By Share Ltd
Original Assignee
Hangzhou Bosheng Medical Laboratory Co ltd
Zhejiang Bosheng Biological Technology Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Bosheng Medical Laboratory Co ltd, Zhejiang Bosheng Biological Technology Ltd By Share Ltd filed Critical Hangzhou Bosheng Medical Laboratory Co ltd
Priority to CN202111210004.9A priority Critical patent/CN114015749A/en
Publication of CN114015749A publication Critical patent/CN114015749A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms

Abstract

The invention discloses a construction method of a mitochondrial genome sequencing library based on high-throughput sequencing and an amplification primer. The amplification primers comprise a primer pair 1 and a primer pair 2; the nucleotide sequence of the primer pair 1 is shown as SEQ ID NO.1 and 2, and the nucleotide sequence of the primer pair 2 is shown as SEQ ID NO.3 and 4. According to the invention, only two pairs of amplification primers are needed, and a sufficient amount of mitochondrial DNA sample can be obtained through one-time PCR amplification, so that the complex primer amount and the cost investment are greatly reduced, and the operation is simplified. According to the invention, the integrity and accuracy of the mtDNA are improved and the effectiveness of data analysis is ensured by mixed database building of amplification products of two pairs of primers.

Description

Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer
Technical Field
The invention belongs to the technical field of high-throughput sequencing, and relates to a construction method of a mitochondrial genome sequencing library based on high-throughput sequencing and an amplification primer.
Background
Mitochondria are factories of cellular energy production and are important organelles of energy metabolism of organisms. The human mitochondrial genome is in a double-chain ring structure, the size is 16569bp, and 13 functional proteins participating in the ATP synthesis process, 22 tRNA and 2 rRNA are coded. Mitochondrial DNA is not protected by histone, is positioned in a highly-oxidized environment and has the characteristic of high mutation rate. These mutations cause changes in gene structure, affect mitochondrial function, cause abnormal oxidative phosphorylation and energy metabolism, and finally cause diseases, such as KSS syndrome, Leigh syndrome and the like.
To detect mutations in mitochondrial DNA, a number of methods are currently available for sequencing mitochondrial DNA. Mutation sites with heterogeneity greater than 10% can be detected by first-generation Sanger sequencing. The sequencing method for mitochondrial DNA based on the high-throughput sequencing technology mainly comprises the following steps: the method comprises the steps of firstly, carrying out mitochondrial DNA separation, separating a mitochondrial genome from cells by cesium chloride density gradient centrifugation, column chromatography, alkali denaturation and other methods, and sequencing; the other is a probe hybridization capture method, which is to synthesize an oligonucleotide probe complementary to mtDNA, capture and enrich target segments after hybridizing with mtDNA, and then carry out high-throughput sequencing; and the third is PCR amplification method, which includes specific amplification of mitochondrial DNA via one or several pairs of primer and subsequent high throughput sequencing.
Traditional generation sequencing technologies have been difficult to adapt to the requirements of mitochondrial genome sequencing due to low sensitivity and high cost. The development of a new generation sequencing technology provides good technical support for the detection of complex and low-frequency mtDNA heterogeneous mutation. The mitochondrial genome yield of cesium chloride gradient centrifugation is low, and the requirements on manpower, time and sample size are high. The probe hybridization capture method is expensive and complicated to operate. In the PCR amplification method, multiple pairs of primers are required to be designed for short-segment amplification, various primer sets are combined for use, the operation is complicated, and the cost is increased; in long fragment amplification, some methods aggregate complete mitochondrial DNA through fragment amplification, but have the defect that amplification cannot be performed when primer binding sites mutate, or have a fragment amplification method capable of mutual correction, but different amplification products need to be subjected to subsequent purification and library construction respectively, so that the workload and the reagent cost are multiplied.
Disclosure of Invention
The invention aims to overcome the defects of the prior art, and provides a simple, economic and rapid mitochondrial DNA PCR amplification primer combination and a sequencing method based on a high-throughput sequencing technology aiming at the limitations of the existing methods in operation or cost. The primer combination only needs two pairs of amplification primers, and a sufficient amount of mitochondrial DNA samples which can be mutually corrected can be obtained through one-time PCR amplification, namely when one pair of primers fails to amplify due to mutation, the other pair of primers can still amplify to obtain a complete DNA sample, and fragments obtained by amplifying the two pairs of primers do not need purification, can be directly merged for subsequent library construction, so that the investment of complex primer amount and cost is greatly reduced, and the operation is simplified.
In order to solve the technical problem, the invention provides a human mitochondrial amplification primer on one hand, which comprises a primer pair 1 and a primer pair 2;
the upstream primer MT1-F of the primer pair 1 is shown as SEQ ID NO.1, the downstream primer MT1-R is shown as SEQ ID NO.2, the upstream primer MT2-F of the primer pair 2 is shown as SEQ ID NO.3, and the downstream primer MT2-R is shown as SEQ ID NO. 4.
The invention also provides a kit for constructing a mitochondrial genome sequencing library, which comprises the human mitochondrial amplification primer.
In another aspect, the present invention provides a method for amplifying a human mitochondrial genome, comprising the steps of:
and (3) carrying out PCR amplification by using the human mitochondrial amplification primer by using the whole blood DNA as a template.
Preferably, the PCR reaction system for PCR amplification comprises: 5 XPrimeSTAR GXL Buffer 10. mu.L, dNTP mix (2.5mM each) 4. mu.L, PrimeSTAR GXL DNApolymerase 1. mu.L, template DNA 1. mu.L, 10. mu.M MT1-F/MT 2-F1. mu.L, 10. mu.M MT1-R/MT 2-R1. mu.L,NF·H2O32μL。
preferably, the PCR reaction procedure of the PCR amplification is: pre-denaturation at 98 ℃ for 2 min; denaturation at 98 ℃ for 10s, annealing/extension at 68 ℃ for 10min, and 32 cycles; prolonging at 68 deg.C for 15 min; then stored at 4 ℃.
The invention also provides a construction method of the mitochondrial genome sequencing library based on high-throughput sequencing, which comprises the following steps:
1) using whole blood DNA as a template, and adopting the human mitochondrial genome amplification method to carry out PCR amplification;
2) and (3) equivalently and uniformly mixing mtDNA obtained by amplifying the two pairs of primers, and constructing a library.
Preferably, the step 2) comprises:
2.1) equally and uniformly mixing mtDNA obtained by amplifying two pairs of primers, and fragmenting by using an ultrasonic disruptor;
2.2) repairing the fragmentation product and adding a single base A at the tail end;
2.3) carrying out a joint connection reaction;
2.4) magnetic bead purification and fragment screening are carried out, and quality control detection is carried out to complete library construction.
As a preferred embodiment of the present invention, the step 2.1): respectively taking 500ng of MT1 product and MT2 product of the same sample, mixing uniformly, and adding nucleic-free ddH2O make up volume to 55 μ L and fragment with an ultrasonic disruptor for 80 s.
The invention further provides a kit for constructing a mitochondrial genome sequencing library, which comprises the human mitochondrial amplification primer. The beneficial effects of the invention include:
(1) through simple PCR amplification of two pairs of primers, a complete and sufficient mtDNA sample can be obtained, complex primer combination pairing is not needed, the operation of personnel is simplified, and the method is economical and rapid;
(2) the integrity and accuracy of the mtDNA are improved and the effectiveness of data analysis is ensured by the mixed database construction of the amplification products of the two pairs of primers.
Drawings
FIG. 1 is a schematic diagram showing the positions of the primer pair MT1 and MT2 and the amplification directions thereof;
FIG. 2 is a gel electrophoresis identification chart of amplification products of the primer pair MT1 and MT 2.
FIG. 3 is mitochondrial sequencing data coverage.
Detailed Description
The technical solution of the present invention will be clearly and completely described below with reference to specific examples, but the present invention is not limited to the following examples.
Taking 4 samples, verifying the invention of the samples, and the specific steps of the implementation process are as follows:
1. extraction and preservation of mtDNA template
And (3) carrying out DNA extraction on the collected peripheral venous blood according to the conventional whole blood DNA extraction process.
2. Primer pair design
Mitochondrial amplification primer pair 1 and primer pair 2 were designed using PrimerPremier 5, with the primer sequences shown in Table 1.
TABLE 1 mtDNA amplification primers
Numbering Primer and method for producing the same Sequence of
SEQ ID NO.1 MT1-F GGTAAAGGTCGGTTTATC
SEQ ID NO.2 MT1-R TATGCCTCTTCACG
SEQ ID NO.3 MT2-F CGATACTCGGACACCC
SEQ ID NO.4 MT2-R AGGGGCGTTTGGTATGG
3. Two pairs of amplification primers are respectively used, whole blood DNA is taken as a template, mtDNA is amplified, and a PCR reaction system is configured on ice as follows:
Figure BDA0003308559190000041
and (3) PCR reaction conditions:
Figure BDA0003308559190000042
the amplification products of MT1 and MT2 were identified by electrophoresis on a 1% agarose gel, and the results are shown in FIG. 2. The product concentration was determined using Qubit.
4. Mitochondrial DNA library construction
Respectively taking 500ng of MT1 product and MT2 product of the same sample, mixing uniformly, and adding nucleic-free ddH2O make up volume to 55 μ L and fragment with an ultrasonic disruptor for 80 s.
Subsequently, the following reaction system was configured:
components Volume/amount
Breaking of the product 50μL
End Prep Mix4 15μL
Total 65μL
The reaction procedure was as follows:
step (ii) of Temperature of
1 105℃
2 20℃
3 65℃
4 4℃
The reaction repairs the broken product and adds A at the tail end, and then carries out the joint connection reaction, and the reaction system is as follows:
components Volume of
Repair product 65μL
Rapid Ligation Buffer3 25μL
Rapid DNA Ligase 5μL
DNAAdapter X 5μL
Total 100μL
The mixture was placed in a PCR apparatus at 20 ℃ for 15 min.
5. Magnetic bead purification and fragment screening
Pipette 60. mu. L VAHTS DNA Clean Beads into 100. mu.L of adaptor ligation and vortex to mix well.
Incubate at room temperature for 5 min.
The PCR tube was briefly centrifuged and placed in a magnetic rack to separate the beads and liquid, and the supernatant carefully removed after the solution cleared (about 5 min).
The PCR tube was kept on the magnetic rack, 200. mu.L of freshly prepared 80% ethanol was added to rinse the beads, and the supernatant carefully removed after incubation at room temperature for 30 s.
The rinsing was repeated once for a total of two rinses.
Keeping the PCR tube on the magnetic frame all the time, opening the cover and air-drying the magnetic beads for 5-10min until no ethanol remains.
Add 105. mu.L of nucleic-free water and vortex at room temperature for 2 min.
The PCR tube was briefly centrifuged and placed in a magnetic stand to stand, and after the solution cleared (about 5min), 100. mu.L of the supernatant was carefully removed to a new EP tube.
Pipette 59. mu. L VAHTS DNA Clean Beads into 100. mu.L of product and vortex well to mix.
Incubate at room temperature for 5 min.
The PCR tube was briefly centrifuged and placed in a magnetic stand to separate the beads from the liquid, after the solution was clarified (about 5min), the supernatant was carefully transferred to a new PCR tube and the beads discarded.
Aspirate 15. mu. L VAHTS DNA CLEAN Beads into the supernatant and vortex.
Incubate at room temperature for 5 min.
The PCR tube was briefly centrifuged and placed in a magnetic rack to separate the beads from the liquid, and after the solution was clarified (about 5min), the supernatant was carefully removed to avoid contact with the beads.
The PCR tube was kept on the magnetic rack, 200. mu.L of freshly prepared 80% ethanol was added to rinse the beads, and after incubation at room temperature for 30sec the supernatant was carefully removed.
The rinsing was repeated once for a total of two rinses.
Keeping the PCR tube on the magnetic frame all the time, opening the cover and air-drying the magnetic beads for 5-10min until no ethanol remains.
The PCR tube was removed from the magnetic stand, 22.5. mu.L of nucleic-free water was added thereto, and the mixture was gently pipetted and mixed, followed by standing at room temperature for 2 min.
The PCR tube was briefly centrifuged and placed in a magnetic rack and left to stand, after the solution cleared (about 5min) 20. mu.L of supernatant was carefully pipetted into a new EP tube, and the beads were removed.
Taking 1 muL library to carry out the Qubit concentration determination and the QIAXcel fragment size determination respectively, wherein the size of the main peak of the library is between 400 and 500bp and is consistent with the size of a theoretical value, and the library construction quality is indicated to be in accordance with the sequencing requirement.
6. DNA library sequencing
The 4 sample libraries were sequenced using Illumina NOVA _ S4 and the data quality analysis is shown in table 2.
TABLE 2 sequencing data quality analysis
Sample_ID Clean_reads Clean_Q30% Average_Depth chrM%
B2020111147 644024 92.19% 11100.04 96.47%
B2020111342 557201 91.85% 9625.2 96.68%
E21020074 515465 91.49% 8863 96.25%
E21030317 659826 92.08% 11460.16 97.28%
The results show that the mitochondrial sequencing data accounts for more than 96%, and the Q30% reaches more than 91%, which indicates that the sequencing data quality is good, and the coverage of mitochondria is shown in figure 3, and the coverage of mtDNA reaches 100%. The detection rate of the positive mutation sites A1555G and A1557G reaches 100 percent, the sequencing depth is 5500 multiplied by more, and the method can be used for simply, quickly and effectively analyzing the human mitochondrial sequence.
The above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
Sequence listing
<110> Zhejiang Bosheng Biotechnology Ltd
Hangzhou Bosheng medical laboratory Co., Ltd
<120> construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 18
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
ggtaaaggtc ggtttatc 18
<210> 2
<211> 14
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
tatgcctctt cacg 14
<210> 3
<211> 16
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
cgatactcgg acaccc 16
<210> 4
<211> 17
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
aggggcgttt ggtatgg 17

Claims (8)

1. A human mitochondrial amplification primer is characterized by comprising a primer pair 1 and a primer pair 2;
the upstream primer MT1-F of the primer pair 1 is shown as SEQ ID NO.1, the downstream primer MT1-R is shown as SEQ ID NO.2, the upstream primer MT2-F of the primer pair 2 is shown as SEQ ID NO.3, and the downstream primer MT2-R is shown as SEQ ID NO. 4.
2. A human mitochondrial genome amplification method is characterized by comprising the following steps:
PCR amplification is carried out using the human mitochondrial amplification primer of claim 1 using whole blood DNA as a template.
3. The amplification method according to claim 2, wherein the PCR reaction system for PCR amplification comprises: 5 XPrimeSTAR GXL Buffer 10. mu.L, dNTP mix (2.5mM each) 4. mu.L, PrimeSTAR GXL DNA Polymerase 1. mu.L, template DNA 1. mu.L, 10. mu.M MT1-F/MT 2-F1. mu.L, 10. mu.M MT1-R/MT 2-R1. mu.L, NF. H2O 32μL。
4. The amplification method according to claim 2, wherein the PCR reaction procedure of the PCR amplification is: pre-denaturation at 98 ℃ for 2 min; denaturation at 98 ℃ for 10s, annealing/extension at 68 ℃ for 10min, and 32 cycles; prolonging at 68 deg.C for 15 min; then stored at 4 ℃.
5. A construction method of a mitochondrial genome sequencing library based on high-throughput sequencing is characterized by comprising the following steps:
1) performing PCR amplification by using a whole blood DNA as a template and using the human mitochondrial genome amplification method according to any one of claims 2 to 4;
2) and (3) equivalently and uniformly mixing mtDNA obtained by amplifying the two pairs of primers, and constructing a library.
6. The building method according to claim 5, wherein the step 2) comprises:
2.1) equally and uniformly mixing mtDNA obtained by amplifying two pairs of primers, and fragmenting by using an ultrasonic disruptor;
2.2) repairing the fragmentation product and adding a single base A at the tail end;
2.3) carrying out a joint connection reaction;
2.4) magnetic bead purification and fragment screening are carried out, and quality control detection is carried out to complete library construction.
7. The construction method according to claim 6, wherein the step 2.1): respectively taking 500ng of MT1 product and MT2 product of the same sample, mixing uniformly, and adding nucleic-free ddH2O make up volume to 55 μ L and fragment with an ultrasonic disruptor for 80 s.
8. A kit for constructing a mitochondrial genome sequencing library, comprising the human mitochondrial amplification primer of claim 1.
CN202111210004.9A 2021-10-18 2021-10-18 Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer Pending CN114015749A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111210004.9A CN114015749A (en) 2021-10-18 2021-10-18 Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111210004.9A CN114015749A (en) 2021-10-18 2021-10-18 Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer

Publications (1)

Publication Number Publication Date
CN114015749A true CN114015749A (en) 2022-02-08

Family

ID=80056557

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111210004.9A Pending CN114015749A (en) 2021-10-18 2021-10-18 Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer

Country Status (1)

Country Link
CN (1) CN114015749A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114480578A (en) * 2022-03-31 2022-05-13 生工生物工程(上海)股份有限公司 Primer set for mitochondrial whole genome sequencing and high-throughput sequencing method
CN117070511A (en) * 2023-08-16 2023-11-17 广州卿泽生物科技有限公司 Primer group for amplifying mitochondrial whole genome and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103614482A (en) * 2013-12-09 2014-03-05 广州赛哲生物科技有限公司 Method for carrying out non-invasive measurement on mitochondrial DNA (deoxyribonucleic acid) based on high-flux gene sequencing
CN105332063A (en) * 2015-08-13 2016-02-17 厦门飞朔生物技术有限公司 Construction method of single-tube and high-flux sequencing library
CN105907748A (en) * 2016-05-10 2016-08-31 广州嘉检医学检测有限公司 Mitochondrial genome library based on high-throughput sequencing and building method thereof
CN107287333A (en) * 2017-08-03 2017-10-24 华子昂 A kind of human mitochondrial total length haplotype is determined and Genetic Variation Analysis method
CN109837274A (en) * 2019-01-30 2019-06-04 浙江大学 A kind of method and application of human mitochondria gene group library construction
CN111172157A (en) * 2020-01-22 2020-05-19 福州福瑞医学检验实验室有限公司 Construction method of human single cell mitochondria high-throughput sequencing library and kit for library construction
CN113308526A (en) * 2021-07-13 2021-08-27 北京爱普益生物科技有限公司 Fusion primer direct amplification method human mitochondrial whole genome high-throughput sequencing kit

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103614482A (en) * 2013-12-09 2014-03-05 广州赛哲生物科技有限公司 Method for carrying out non-invasive measurement on mitochondrial DNA (deoxyribonucleic acid) based on high-flux gene sequencing
CN105332063A (en) * 2015-08-13 2016-02-17 厦门飞朔生物技术有限公司 Construction method of single-tube and high-flux sequencing library
CN105907748A (en) * 2016-05-10 2016-08-31 广州嘉检医学检测有限公司 Mitochondrial genome library based on high-throughput sequencing and building method thereof
CN107287333A (en) * 2017-08-03 2017-10-24 华子昂 A kind of human mitochondrial total length haplotype is determined and Genetic Variation Analysis method
CN109837274A (en) * 2019-01-30 2019-06-04 浙江大学 A kind of method and application of human mitochondria gene group library construction
CN111172157A (en) * 2020-01-22 2020-05-19 福州福瑞医学检验实验室有限公司 Construction method of human single cell mitochondria high-throughput sequencing library and kit for library construction
CN113308526A (en) * 2021-07-13 2021-08-27 北京爱普益生物科技有限公司 Fusion primer direct amplification method human mitochondrial whole genome high-throughput sequencing kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
孙嘉仪等: "一种基于多重PCR的人类线粒体基因组高通量测序方法", 《中国科学(生命科学)》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114480578A (en) * 2022-03-31 2022-05-13 生工生物工程(上海)股份有限公司 Primer set for mitochondrial whole genome sequencing and high-throughput sequencing method
CN114480578B (en) * 2022-03-31 2023-08-18 生工生物工程(上海)股份有限公司 Primer set for mitochondrial whole genome sequencing and high-throughput sequencing method
CN117070511A (en) * 2023-08-16 2023-11-17 广州卿泽生物科技有限公司 Primer group for amplifying mitochondrial whole genome and application thereof
CN117070511B (en) * 2023-08-16 2024-02-02 广州卿泽生物科技有限公司 Primer group for amplifying human mitochondrial whole genome and application thereof

Similar Documents

Publication Publication Date Title
CN106591441B (en) Alpha and/or beta-thalassemia mutation detection probe, method and chip based on whole gene capture sequencing and application
CN106906211B (en) Molecular joint and application thereof
WO2016049878A1 (en) Snp profiling-based parentage testing method and application
CN106350590B (en) DNA library construction method for high-throughput sequencing
CN114015749A (en) Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer
CN110878334B (en) Primer for sequencing amplicon and two-step PCR library building method
CN111378732B (en) Mitochondrial genome sequencing primer, kit and method
CN109295500B (en) Single cell methylation sequencing technology and application thereof
CN105803054A (en) Kit and use thereof in detection of orofacial clefts related genes
CN112592981B (en) Primer group, kit and method for DNA archive construction
CN109280696B (en) Method for splitting mixed sample by SNP detection technology
CN111748628B (en) Primer and kit for detecting thyroid cancer prognosis related gene variation
CN116083529B (en) Method for targeted enrichment of DNA of genome target region and application thereof
CN111748637A (en) SNP molecular marker combination, multiplex composite amplification primer set, kit and method for genetic relationship analysis and identification
CN113564266B (en) SNP typing genetic marker combination, detection kit and application
CN110564838B (en) Multiplex PCR primer system for genotyping of neonatal glycogen storage disease and use thereof
CN105603052B (en) Probe and use thereof
CN111172260A (en) Method and kit for detecting mitochondrial genome in human urine or blood sample
CN113151428A (en) Method and device for detecting sample confusion in library construction process
CN111944806A (en) Molecular tag group for high-throughput sequencing pollution detection and application thereof
CN111172159A (en) Bovine mitochondrial genome capture probe kit
CN111378653A (en) Primer, kit and method for detecting SCA gene mutation
CN109355288B (en) Method for enriching target DNA and application
CN110819710A (en) High-throughput sequencing detection of myeloid tumors
CN117070511B (en) Primer group for amplifying human mitochondrial whole genome and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220208